Showing 1,941 - 1,960 results of 18,609 for search 'significantly ((((((lower decrease) OR (greater decrease))) OR (a decrease))) OR (linear decrease))', query time: 0.64s Refine Results
  1. 1941
  2. 1942

    Image1_Kidney outcomes associated with SGLT2 inhibitors compared to other glucose-lowering drugs: a real-world study from China.TIF by Xiang Xiao (44417)

    Published 2024
    “…Throughout the follow-up period, we observed a significant decrease in the rate of eGFR decline in patients using SGLT2i (4.94 mL/min/1.73 m<sup>2</sup> per year reduction compared to oGLDs, 95% CI: 4.73–5.15). …”
  3. 1943

    Image2_Kidney outcomes associated with SGLT2 inhibitors compared to other glucose-lowering drugs: a real-world study from China.TIF by Xiang Xiao (44417)

    Published 2024
    “…Throughout the follow-up period, we observed a significant decrease in the rate of eGFR decline in patients using SGLT2i (4.94 mL/min/1.73 m<sup>2</sup> per year reduction compared to oGLDs, 95% CI: 4.73–5.15). …”
  4. 1944

    Image8_Kidney outcomes associated with SGLT2 inhibitors compared to other glucose-lowering drugs: a real-world study from China.TIF by Xiang Xiao (44417)

    Published 2024
    “…Throughout the follow-up period, we observed a significant decrease in the rate of eGFR decline in patients using SGLT2i (4.94 mL/min/1.73 m<sup>2</sup> per year reduction compared to oGLDs, 95% CI: 4.73–5.15). …”
  5. 1945

    Image5_Kidney outcomes associated with SGLT2 inhibitors compared to other glucose-lowering drugs: a real-world study from China.TIF by Xiang Xiao (44417)

    Published 2024
    “…Throughout the follow-up period, we observed a significant decrease in the rate of eGFR decline in patients using SGLT2i (4.94 mL/min/1.73 m<sup>2</sup> per year reduction compared to oGLDs, 95% CI: 4.73–5.15). …”
  6. 1946

    Image6_Kidney outcomes associated with SGLT2 inhibitors compared to other glucose-lowering drugs: a real-world study from China.TIF by Xiang Xiao (44417)

    Published 2024
    “…Throughout the follow-up period, we observed a significant decrease in the rate of eGFR decline in patients using SGLT2i (4.94 mL/min/1.73 m<sup>2</sup> per year reduction compared to oGLDs, 95% CI: 4.73–5.15). …”
  7. 1947

    Image3_Kidney outcomes associated with SGLT2 inhibitors compared to other glucose-lowering drugs: a real-world study from China.TIF by Xiang Xiao (44417)

    Published 2024
    “…Throughout the follow-up period, we observed a significant decrease in the rate of eGFR decline in patients using SGLT2i (4.94 mL/min/1.73 m<sup>2</sup> per year reduction compared to oGLDs, 95% CI: 4.73–5.15). …”
  8. 1948

    Image4_Kidney outcomes associated with SGLT2 inhibitors compared to other glucose-lowering drugs: a real-world study from China.TIF by Xiang Xiao (44417)

    Published 2024
    “…Throughout the follow-up period, we observed a significant decrease in the rate of eGFR decline in patients using SGLT2i (4.94 mL/min/1.73 m<sup>2</sup> per year reduction compared to oGLDs, 95% CI: 4.73–5.15). …”
  9. 1949

    Image7_Kidney outcomes associated with SGLT2 inhibitors compared to other glucose-lowering drugs: a real-world study from China.TIF by Xiang Xiao (44417)

    Published 2024
    “…Throughout the follow-up period, we observed a significant decrease in the rate of eGFR decline in patients using SGLT2i (4.94 mL/min/1.73 m<sup>2</sup> per year reduction compared to oGLDs, 95% CI: 4.73–5.15). …”
  10. 1950

    DataSheet1_Pharmacological inhibition of receptor protein tyrosine phosphatase β/ζ decreases Aβ plaques and neuroinflammation in the hippocampus of APP/PS1 mice.docx by Teresa Fontán-Baselga (20392470)

    Published 2024
    “…In addition, we observed a significant decrease in the number and size of astrocytes in both sexes and in the number of microglial cells in a sex-dependent manner. …”
  11. 1951
  12. 1952

    Manhattan plot for genome-wide association study (GWAS) in a European population with depression. by Xiaomei He (795333)

    Published 2025
    “…<p>A: The x-axis represents the chromosomal position, and the y-axis represents the significance on a –log10 scale. …”
  13. 1953
  14. 1954
  15. 1955
  16. 1956

    Basic physical parameters of shield residue. by Shoujie Wang (18326754)

    Published 2024
    “…The results show that the UCS and CBR values enhanced significantly with the increase in curing time. However, the moisture content and pH of the stabilized soil exhibited a decreasing trend. …”
  17. 1957

    Primary composition of experimental materials. by Shoujie Wang (18326754)

    Published 2024
    “…The results show that the UCS and CBR values enhanced significantly with the increase in curing time. However, the moisture content and pH of the stabilized soil exhibited a decreasing trend. …”
  18. 1958

    Compaction test results. by Shoujie Wang (18326754)

    Published 2024
    “…The results show that the UCS and CBR values enhanced significantly with the increase in curing time. However, the moisture content and pH of the stabilized soil exhibited a decreasing trend. …”
  19. 1959

    Experimental mix proportions. by Shoujie Wang (18326754)

    Published 2024
    “…The results show that the UCS and CBR values enhanced significantly with the increase in curing time. However, the moisture content and pH of the stabilized soil exhibited a decreasing trend. …”
  20. 1960

    CBR test results. by Shoujie Wang (18326754)

    Published 2024
    “…The results show that the UCS and CBR values enhanced significantly with the increase in curing time. However, the moisture content and pH of the stabilized soil exhibited a decreasing trend. …”